Trials / Active Not Recruiting
Active Not RecruitingNCT06393946
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
Observational Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Treated With Dupilumab in France
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, non-interventional, single arm study that aims to describe the treatment patterns in France: patients' characteristics, disease characteristics, prior treatments for Severe chronic rhinosinusitis with nasal polyposis and treatment prescription modalities. As well as to assess the clinical outcome after initiation of dupilumab (Dupixent®) and safety of the product during the two years of treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dupilumab | This study will not administer any treatment, only observe the treatment as prescribed in real world-clinical practice. |
Timeline
- Start date
- 2023-10-20
- Primary completion
- 2026-04-28
- Completion
- 2026-07-31
- First posted
- 2024-05-01
- Last updated
- 2025-12-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06393946. Inclusion in this directory is not an endorsement.